NCT01232023View on ClinicalTrials.gov

Evaluation of Pharmacokinetic and Pharmacodynamic Characteristics of Indobufen, an Anticoagulant Agent

PHASE1UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

December 31, 2010

Conditions
Healthy
Interventions
DRUG

Indobufen

Single Oral Dose of

Trial Locations (2)

Unknown

RECRUITING

Pusan National University Yangsan Hospital, Pusan

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT01232023 - Evaluation of Pharmacokinetic and Pharmacodynamic Characteristics of Indobufen, an Anticoagulant Agent | Biotech Hunter | Biotech Hunter